FDA
-
-
-
-
-
-
-
BriaCell expands Phase 3 breast cancer study to 79 clinical sites
-
-
-
-
-
-
-
BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven
-
-
-
-
-
-
-
BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)
-
-
-
-
-
-
-
Briacell Therapeutics (BCTX) PT Lowered to $15 at H.C. Wainwright
-
-
-
-
-
-
-
BriaCell Therapeutics (BCTX) Reports Positive Survival Data in Advanced Metastatic Breast Cancer
-
-
-
-
-
-
-
BriaCell Announces Positive Clinical and Quality of Life Data in Advanced Metastatic Breast Cancer at 2022 San Antonio Breast Cancer Symposium®
-
-
-
-
-
-
-
Pre-Open Stock Movers 04/13: (ATRS) (SRRA) (STAB) Higher; (NSTG) (LQDA) (BBBY) Lower (more...)
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

